438 Results
4

U.S News. & World Report: Is it allergies or sinusitis? Many folks are misdiagnosed

February 28, 2024

What if you'd been treated for years for a condition, only to find out that you'd long ago been misdiagnosed? That's what's happening to a sizable number of Americans who are taking allergy meds (to little effect) when in fact they have chronic rhinosinusitis (CRS), a new UC study contends. US News and World Report published a report on the research, interviewing the lead author Ahmad Sedaghat of the UC College of Medicine.

5

WVXU: Has COVID become another routine respiratory infection?

February 28, 2024

The Centers for Disease Control and Prevention could soon change its isolation guidance for people who have tested positive for COVID, according to recent media reports. The agency is considering new guidelines where workers and school-aged children would not be required to isolate before returning to school or work if they have been fever-free for at least 24 hours without medication and if their symptoms are mild or resolving. WVXU interviewed Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine to get his insight.

7

New York Times: What to know about lead exposure in children

February 27, 2024

A recent outbreak of lead poisoning from cinnamon in applesauce has drawn attention to the toxic effect the heavy metal can have on children. The cinnamon in the applesauce was believed to have been intentionally contaminated, possibly to add to its value as a commodity sold by weight. The New York Times published an article on the outbreak, quoting Kim Dietrich, PhD, of the Department of Environmental and Public Health Sciences at the UC College of Medicine.

8

UC research examines chronic sinusitis

February 26, 2024

According to the National Institutes for Health, chronic sinusitis, also known as chronic rhinosinusitis (CRS), affects approximately 14.6% of the United States population and is currently the fifth most common condition treated with antibiotics, accounting for up to 22 million physician visits and costing as much as $5 billion annually. New research from the University of Cincinnati examines the incidence of people suffering from allergy symptoms who actually have CRS, a finding that could impact how those symptoms are treated. The research was published in the journal Otolaryngology - Head and Neck Surgery.

10

UC joins clinical trial to test treatment for abdominal injury

February 16, 2024

Researchers at the University of Cincinnati are part of a clinical study for ResQFoam, a new device for the treatment of life-threatening abdominal internal bleeding. UC Medical Center is one of a handful of Level I Trauma Centers in the United States selected to participate in the multicenter Reducing Exsanguination Via In‐Vivo Expandable Foam (REVIVE) study.